Furthermore, the percentage of CD24 + cells correlated with cisplatin resistance in HNSCC cell lines, and CD24 knockdown significantly reduced NANOG expression and sensitized cells to cisplatin treatment. This evidence concerns the gene NANOG and head and neck squamous cell carcinoma.